Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement
- Supplementary File 1:
ZIP-Document (ZIP, 8689 KiB)
Coban, M.A.; Morrison, J.; Maharjan, S.; Hernandez Medina, D.H.; Li, W.; Zhang, Y.S.; Freeman, W.D.; Radisky, E.S.; Le Roch, K.G.; Weisend, C.M.; Ebihara, H.; Caulfield, T.R. Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement. Biomolecules 2021, 11, 787. https://doi.org/10.3390/biom11060787
Coban MA, Morrison J, Maharjan S, Hernandez Medina DH, Li W, Zhang YS, Freeman WD, Radisky ES, Le Roch KG, Weisend CM, Ebihara H, Caulfield TR. Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement. Biomolecules. 2021; 11(6):787. https://doi.org/10.3390/biom11060787
Chicago/Turabian StyleCoban, Mathew A., Juliet Morrison, Sushila Maharjan, David H. Hernandez Medina, Wanlu Li, Yu S. Zhang, William D. Freeman, Evette S. Radisky, Karine G. Le Roch, Carla M. Weisend, Hideki Ebihara, and Thomas R. Caulfield. 2021. "Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement" Biomolecules 11, no. 6: 787. https://doi.org/10.3390/biom11060787